(Total Views: 429)
Posted On: 09/25/2021 11:25:10 AM
Post# of 155062
It was good too see a plan but still no CEO candidate.
The cancer stuff is obvious.
I would expect that each of the pharma’s listed May have already spoken to Cytodyn.
It is real easy to list potential partners but much harder to negotiate a good deal with a partner - especially as a small biotech.
None of their people have inked big deals with pharma companies as far as I can tell.
BP has had saleable products for some time now yet has had to raise nearly $2 million last year in notes. Means company is likely not profitable - not a great resume if you have saleable products and still loose money
All IMO
The cancer stuff is obvious.
I would expect that each of the pharma’s listed May have already spoken to Cytodyn.
It is real easy to list potential partners but much harder to negotiate a good deal with a partner - especially as a small biotech.
None of their people have inked big deals with pharma companies as far as I can tell.
BP has had saleable products for some time now yet has had to raise nearly $2 million last year in notes. Means company is likely not profitable - not a great resume if you have saleable products and still loose money
All IMO
(7)
(0)
